CRISPR Screen Identifies Genetic Modifiers of ALS

While much of the genetics surrounding amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) has been enigmatic for decades, new gene-editing techniques—such as CRISPR/Cas9 —are beginning to help uncover genes in the human genome that may modify the severity of these neurological disorders. Researchers at Stanford University just published their recent findings in Nature Genetics in an article entitled “ CRISPR-Cas9 Screens in Human Cells and Primary Neurons Ide